Osteoporosis

January 22, 2021

“Based on 16,235 pairs of zoledronic acid and denosumab initiators (for osteoporosis), we found a greater risk (HR 1.25, 95% CI 1.04-1.50) of atrial fibrillation with zoledronic acid vs denosumab: an absolute risk difference of 3.69 events per 1000 person-years,” said Seoyoung Kim, MD, ScD.

January 19, 2021

Dr Joan Lo, MD, a research scientist with the Kaiser Permanente Northern California Division of Research, said: “We found that hip fracture risk in women did not differ if women stopped bisphosphonate use after five years or stayed on the medication for 10 years. Whether there is a benefit to staying on the drug for seven years needs to be further studied in randomized trials.”

January 07, 2021

“Bone mineral density screening rates remain low, as do calcium/vitamin D supplementation and primary prophylaxis with anti-osteoporotic therapy," lead author Eileen Rife, MD, said.

January 06, 2021

The results of a study presented at ACR 2020 demonstrate that a greater proportion of patients were initiated on denosumab compared with bisphosphonates for the first time—18.5% compared with 16.9%— in 2018.

December 18, 2020

“The main take home message is to pay attention to the prevention and treatment of GIOP while prescribing steroids to the patients because the side effects is steroids are not benign," Shikha Singla, MD, said.

December 15, 2020

Findings from a study presented at ACR 2020 showed a clear difference in co-morbidities and medication use associated with osteoporosis at different lumbar levels. Here, a Q&A with the co-author.

December 10, 2020

Young men with distal radius fracture are likely to have hormonal imbalances suggests the first study to look at sex hormone levels in younger men experiencing fractures.

December 10, 2020

Non-heterosexual minority men have a greater risk of poor bone health than heterosexual men, and this risk appears to be independent of lifestyle and psychosocial factors, suggests a study published in the American Journal of Human Biology.

December 04, 2020

Stories on COVID-19 were no doubt among our most read stories in 2020, but so too were stories on diet and rheumatic disease, rheumatoid arthritis treatment options, a new treatment for osteoarthritis and a story about selecting appropriate exercise regimens for rheumatic conditions. In this slideshow, we highlight the stories that resonated most with our readers in 2020.

November 25, 2020

In this interview, Jeffrey Curtis, M.D., of the University of Alabama at Birmingham, addresses osteoporosis in men. It's more common than physicians may realize. "It is often misconstrued as a disease that mainly, if not only, effects Caucasian women, which is not the case,” he said.